Its part of a letter written to the World Health Organization (WHO) on behalf of e-cigarettes and vaping. The letter is authored by over a dozen health experts from around the world who say "We respectfully suggest that the following principles should underpin the public health approach to tobacco harm reduction, with global leadership from WHO:"
The quote is item #3: "On a precautionary basis, regulators should avoid support for measures that could have the perverse effect of prolonging cigarette consumption. Policies that are excessively restrictive or burdensome on lower risk products can have the unintended consequence of protecting cigarettes from competition from less hazardous alternatives, and cause harm as a result. Every policy related to low risk, non-combustible nicotine products should be assessed for this risk."
Imagine the concept of "unintended consequences" and vaping.
I doubt very much that snuffing out vaping (no pun intended) is an "unintended consequence."
Look at this article about how the North Dakota legislature has determined that vaping is not a tobacco product.
It seems as if the truth is accidentally leaked out by Rep. Eliot Glassheim: "“The issue is this bill has a definition which preempts these devices as being considered tobacco products,” said Rep. Eliot Glassheim, D-Grand Forks. “It’s a new definition, and it seems to me it’s a stealth way of not being able to tax them in later bills”" (underline my own).
Declaring vaping a "non-tobacco product" is "stealth way" of not being able to tax it...?
Poor Eliot doesn't seem to have gotten the memo here...
Eliot, please be advised that regardless of how "healthy" vaping might be your lobbyists and cronies will be very unhappy if vaping is not made into tobacco. However, Eliot, you're not supposed to actual say this.
Instead you are supposed to say "vaping will harm children" or "no one knows what vaping will do" to someone's future.
Those are the acceptable responses.
Perhaps the letter, written last year, should be more carefully considered Mr. Eliot.
After all, if someone dies from a smoking related illness, it would seem Mr. Eliot has put lining his pockets ahead of saving a human life.
The signatories to the aforementioned letter, by the way, are as follow:
Signatories this statement at 26 May 2014
Professor David Abrams Professor of Health Behavior and Society. The Johns Hopkins Bloomberg School of Public Health. Maryland. USA. Professor of Oncology (adjunct). Georgetown University Medical Center, Lombardi Comprehensive Cancer Center. Washington DC. United States of America Professor Tony Axéll Emeritus Professor Geriatric Dentistry Consultant in Oral Medicine Sweden Professor Pierre Bartsch Respiratory physician, Faculty of Medicine University of Liège Belgium Professor Linda Bauld Professor of Health Policy Director of the Institute for Social Marketing Deputy Director, UK Centre for Tobacco and Alcohol Studies University of Stirling United Kingdom Professor Ron Borland Nigel Gray Distinguished Fellow in Cancer Prevention at Cancer Council Victoria Professorial Fellow School of Population Health and Department of Information Systems University of Melbourne, Australia Professor John Britton Professor of Epidemiology; Director, UK Centre for Tobacco & Alcohol Studies, Faculty of Medicine & Health Sciences University of Nottingham, United Kingdom Associate Professor Chris Bullen Director, National Institute for Health Innovation School of Population Health, University of Auckland, New Zealand Professor Emeritus André Castonguay Faculty of Pharmacy Université Laval, Quebec, Dr Lynne Dawkins Senior Lecturer in Psychology, Co-ordinator: Drugs and Addictive Behaviours Research Group School of Psychology, University of East London, United Kingdom Professor Ernest Drucker Professor Emeritus Department of Family and Social Medicine, Montefiore Medical Center/Albert Einstein College of Medicine Mailman School of Public Health Columbia University United States of America Professor Jean François Etter Associate Professor Institut de santé globale, Faculté de médecine, Université de Genève, Switzerland Dr Karl Fagerström President, Fagerström Consulting AB, Vaxholm, Sweden Dr Konstantinos Farsalinos Researcher, Onassis Cardiac Surgery Center, Athens, Greece Researcher, University Hospital Gathuisberg, Leuven, Belgium Professor Antoine Flahault Directeur de l’Institut de Santé Globale Faculté de Médecine, Université de Genève, Suisse/ Institute of Global Health, University of Geneva, Switzerland Professor of Public Health at the Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, France Dr Coral Gartner Senior Research Fellow University of Queensland Centre for Clinical Research The University of Queensland, Australia Dr Guillermo González Psychiatrist Comisión de Rehabilitación en Enfermedad Mental Grave Clínica San Miguel Madrid, Spain Dr Nigel Gray Member of Special Advisory Committee on Tobacco Regulation of the World Health Organization Honorary Senior Associate Cancer Council Victoria Australia Professor Peter Hajek Professor of Clinical Psychology and Director, Health and Lifestyle Research Unit UK Centre for Tobacco and Alcohol Studies Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry Queen Mary University of London, United Kingdom Professor Wayne Hall Director and Inaugural Chair, Centre for Youth Substance Abuse Research University of Queensland Australia Professor John Hughes Professor of Psychology, Psychiatry and Family Practice University of Vermont United States of America Professor Martin Jarvis Emeritus Professor of Health Psychology Department of Epidemiology & Public Health University College London, United Kingdom Professor Didier Jayle Professeur d’addictologie Conservatoire National des Arts et Métiers Paris, France Dr Martin Juneau Directeur, Direction de la Prévention Institut de Cardiologie de Montréal Professeur Titulaire de Clinique Faculté de Médecine, Université de Montréal, Canada Dr Michel Kazatchkine Member of the Global Commission on Drug Policy Senior fellow, Global Health Program, Graduate institute, Geneva, Switzerland Professor Demetrios Kouretas School of Health Sciences and Vice Rector University of Thessaly, Greece Professor Lynn Kozlowski Dean, School of Public Health and Health Professions, Professor of Community Health and Health Behavior, University at Buffalo, State University of New York, United States of America Professor Eva Králíková Institute of Hygiene and Epidemiology Centre for Tobacco-Dependence First Faculty of Medicine Charles University in Prague and General University Hospital in Prague, Czech Republic Professor Michael Kunze Head of the Institute for Social Medicine Medical University of Vienna, Austria Dr Murray Laugesen Director Health New Zealand, Lyttelton, Christchurch, New Zealand Dr Jacques Le Houezec Consultant in Public Health, Tobacco dependence, Rennes, France Honorary Lecturer, UK Centre for Tobacco Control Studies, University of Nottingham, United Kingdom Dr Kgosi Letlape President of the Africa Medical Association Former President of the World Medical Association Former Chairman of Council of the South African Medical Association South Africa Dr Karl Erik Lund Research director Norwegian Institute for Alcohol and Drug Research, Oslo, Norway Dr Gérard Mathern Président de l’Institut Rhône-Alpes de Tabacologie Saint-Chamond, France Professor Richard Mattick NHMRC Principal Research Fellow Immediate Past Director NDARC (2001-2009) National Drug and Alcohol Research Centre (NDARC) Faculty of Medicine The University of New South Wales, Australia Professor Ann McNeill Professor of Tobacco Addiction Deputy Director, UK Centre for Tobacco and Alcohol Studies National Addiction Centre Institute of Psychiatry King’s College London, United Kingdom Dr Hayden McRobbie Reader in Public Health Interventions, Wolfson Institute of Preventive Medicine, Queen Mary University of London, United Kingdom Dr Anders Milton Former President of the Swedish Red Cross Former President and Secretary of the Swedish Medical Association Former Chairman of the World Medical Association Owner & Principal Milton Consulting, Sweden Professor Marcus Munafò Professor of Biological Psychology MRC Integrative Epidemiology Unit at the University of Bristol UK Centre for Tobacco and Alcohol Studies School of Experimental Psychology University of Bristol, United Kingdom Professor David Nutt Chair of the Independent Scientific Committee on Drugs (UK) Edmund J Safra Professor of Neuropsychopharmacology Head of the Department of Neuropsychopharmacology and Molecular Imaging Imperial College London, United Kingdom Dr Gaston Ostiguy Professeur agrégé Directeur de la Clinique de cessation tabagique Centre universitaire de santé McGill (CUSM) Institut thoracique de Montréal, Canada Professor Riccardo Polosa Director of the Institute for Internal Medicine and Clinical Immunology, University of Catania, Italy. Dr Lars Ramström Director Institute for Tobacco Studies Täby, Sweden Dr Martin Raw Special Lecturer UK Centre for Tobacco and Alcohol Studies Division of Epidemiology and Public Health University of Nottingham, United Kingdom Professor Andrzej Sobczak Department of General and Inorganic Chemistry, Faculty of Pharmacy and Laboratory Medicine, Medical University of Silesia, Katowice, Poland Institute of Occupational Medicine and Environmental Health Sosnowiec, Poland Professor Gerry Stimson Emeritus Professor, Imperial College London; Visiting Professor, London School of Hygiene and Tropical Medicine United Kingdom Professor Tim Stockwell Director, Centre for Addictions Research of BC Professor, Department of Psychology University of Victoria, British Columbia, Canada Professor David Sweanor Adjunct Professor, Faculty of Law, University of Ottawa Special Lecturer, Division of Epidemiology and Public Health, University of Nottingham, United Kingdom Professor Umberto Tirelli Director Department of Medical Oncology National Cancer Institute of Aviano Italy Professor Umberto Veronesi Scientific Director IEO Istituto Europeo di Oncologia Former Minister of Health, Italy Professor Kenneth Warner Avedis Donabedian Distinguished University Professor of Public Health Professor, Health Management & Policy School of Public Health University of Michigan United States of America Professor Robert West Professor of Health Psychology and Director of Tobacco Studies Health Behaviour Research Centre, Department of Epidemiology & Public Health, University College London United Kingdom Professor Dan Xiao Director of Department Epidemiology WHO Collaborating Center for Tobacco or Health Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, China Dr Derek Yach Former Executive Director, Non-Communicable Diseases Former Head of Tobacco Free Initiative, World Health Organisation (1995-2004) Senior Vice President Vitality Group plc Director, Vitality Institute for Health Promotion United States of America